03477nam a22004935i 45000010014000000030009000140050017000230060019000400070015000590080041000740200018001150240031001330350021001640350022001850400033002070410008002400440015002480500026002630720023002890820025003121000089003372450122004262640057005482640011006053000031006163360026006473370026006733380036006993470024007354900037007595050459007965060104012555201040013595380049023995460016024485880112024646500051025767730101026278560042027288560049027708560068028199120072028879120024029599780804786577DE-B159720200915044058.0m|||||o||d||||||||cr || ||||||||200915t20202013cau    fo  d z      eng d  a97808047865777 a10.1515/97808047865772doi  a(DE-B1597)563694  a(OCoLC)1198930135  aDE-B1597bengcDE-B1597erda0 aeng  acaucUS-CA 4aRA401.C35bG63 2013eb 7aSOC0260002bisacsh04a338.4/76151097282231 aGodoy, Angelina Snodgrass, eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aOf Medicines and Markets :bIntellectual Property and Human Rights in the Free Trade Era /cAngelina Snodgrass Godoy. 1aStanford, CA : bStanford University Press, c[2020] 4cÂ©2013  a1 online resource (208 p.)  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aStanford Studies in Human Rights00tFrontmatter -- tContents -- tForeword -- tAcronyms and Abbreviations -- tAcknowledgments -- t1. Trading Health for Wealth -- t2. A Primer on Pharmaceutical Intellectual Property -- t3. Market Failures and Fallacies -- t4. Local Politics, Strange Bedfellows, and the Challenges of Human Rights Mobilization -- t5. Patient Advocacy and Access to Medicines Litigation -- t6. Writing Globalization's Rule Book -- tNotes -- tReferences -- tIndex 0 arestricted accessuhttp://purl.org/coar/access_right/c_16ecfonline access with authorization2star  aCentral American countries have long defined health as a human right. But in recent years regional trade agreements have ushered in aggressive intellectual property reforms, undermining this conception. Questions of IP and health provisions are pivotal to both human rights advocacy and "free" trade policy, and as this book chronicles, complex political battles have developed across the region. Looking at events in Costa Rica, El Salvador, and Guatemala, Angelina Godoy argues that human rights advocates need to approach intellectual property law as more than simply a roster of regulations. IP represents the cutting edge of a global tendency to value all things in market terms: Life forms-from plants to human genetic sequences-are rendered commodities, and substances necessary to sustain life-medicines-are restricted to insure corporate profits. If we argue only over the terms of IP protection without confronting the underlying logic governing our trade agreements, then human rights advocates will lose even when they win.  aMode of access: Internet via World Wide Web.  aIn English.0 aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 15. Sep 2020) 7aSOCIAL SCIENCE / Sociology / General.2bisacsh08iTitle is part of eBook package:dDe GruytertSUP Backlist eBook-Package 2000-2013z978311070420440uhttps://doi.org/10.1515/978080478657740uhttps://www.degruyter.com/isbn/9780804786577423Coveruhttps://www.degruyter.com/cover/covers/9780804786577.jpg  a978-3-11-070420-4  SUP Backlist eBook-Package 2000-2013c2000d2013  aGBV-deGruyter-alles